Silvio Danese to Janus Kinase Inhibitors
This is a "connection" page, showing publications Silvio Danese has written about Janus Kinase Inhibitors.
Connection Strength
0.959
-
Janus kinase inhibitors for the treatment of inflammatory bowel diseases: developments from phase I and phase II clinical trials. Expert Opin Investig Drugs. 2018 07; 27(7):595-599.
Score: 0.481
-
JAK inhibitors: Novel developments in management of ulcerative colitis. Best Pract Res Clin Gastroenterol. 2018 Feb - Apr; 32-33:89-93.
Score: 0.477